Non-traded business development companies have been limiting withdrawals, suggesting investor concerns about private credit.

Nvidia's dividend up until now has been fairly nominal, just a single cent. But the dividend it recently announced will be ...

But shortly thereafter, speculative frenzy emerged about Viking Therapeutics and its VK2735 weight-loss drug candidate. While similar to Zepbound -- both are dual agonists that bind to both GLP-1 and ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

SoundHound recently introduced its Oasys platform, which it says is "the world's first self-learning orchestrated agentic AI ...

Fortunately, benefits aren't locked in place forever. The 2027 cost-of-living adjustment (COLA) will give seniors a benefit ...

The shift toward custom processors in AI hardware is opening the door for these stocks to challenge Nvidia's dominance.

Nvidia's smaller peers are expected to deliver stronger earnings growth amid fast-growing demand for inference-focused AI ...

This artificial intelligence company offers compelling value, but Ackman says there are even better opportunities.

Fully 64% of survey respondents didn't understand the impact of Social Security's surplus running dry. When asked about what ...

It's very clear that 2026's Social Security cost-of-living adjustment, or COLA, is not holding up well to inflation. And ...

Mike Wirth, the CEO of Chevron (CVX +0.22%), has been openly warning the world about the impact of the geopolitical conflict ...